Fengyi Technology Files for HKEX Listing, Aiming to Be "The First Smart Retail Cabinet Stock"
NewTimeSpace News: As disclosed by HKEX, Shenzhen Fengyi Technology Group Co., Ltd. filed its Main Board listing application with the Hong Kong Stock Exchange on June 10, 2026, with ABC International serving as the sole sponsor.
Fengyi Technology is an AI-powered retail enterprise. Per Frost & Sullivan data, it is China's largest smart retail cabinet operator measured by the number of installed retail cabinets and gross merchandise volume in 2025. The company develops smart retail cabinets at roughly 30% of the cost of traditional vending machines, and has created a shopping experience featuring "scan code to open door and automatic settlement upon door closing". As of December 31, 2025, the company's service network covered 183,980 locations across 72 cities, having served more than 80 million cumulative consumers.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- SHENYANG PUBLIC (00747.HK): Disposes of 100% Equity Interest in Target Company for RMB 2 Million, Expects Gain of About RMB 33.55 Million
- NEWLINK TECH (09600.HK): Termination of Memorandum of Intent on Equity Acquisition; Proposed Acquisition Will Not Proceed
- LANCANG TEA (06911.HK): Subsidiary's RMB 24.9 Million Working Capital Loan Extended by One Year, Company Continues to Provide Guarantee
- Going Global Weekly: Mainland Companies Flock to Hong Kong Listings, Pharma Globalisation Shifts to Data and Capability Export-20260918
- TRANSTHERA-B (02617.HK): Tinengotinib Included in CSCO Guidelines for Biliary Tract Malignancies (2026)